JPRN-UMIN000010629招募中未知
Percutaneous transvenous aortic valvuloplasty with a new method - Percutaneous transvenous aortic valvuloplasty with a new method
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University0 个研究点目标入组 2 人开始时间: 2013年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Acute myocardial infarction within 1 month. 2. Unicuspid aortic valve. 3. Severe aortic valve regurgitation. 4. Prior valve surgery. 5. Need of the emergency surgery by some kind of reasons why an aortic stenosis does not have relations. 6.Obstructive or nonobstructive cardiomyopathy. 7. Severe LV dysfunction (LVEF<20%). 8. Active gastrointestinal ulcer or history of upper gastrointestinal bleeding within 3 months. 9. Allergy to heparin. 10. CVA or TIA within 6 month. 11. Life expectancy less than 12 months due to non-cardiac disease. 12. Involvement in another clinical trial. 13. Allergy to latex. 14. Making the safe insertion of sheath introducer impossible by thrombosis from the common iliac vein through the femoral vein. 15. Cardiologist and cardiovascular surgeon decision not to register to this study.
研究者
相似试验
已完成
不适用
Transcatheter aortic valve implantation for aortic stenosis registryAortic stenosisJPRN-UMIN000023705Keio University Hospital800
已完成
不适用
ew Transcatheter Aortic Valve Implantation (TAVI) GuidewireAortic stenosis, cardiovascular diseaseCirculatory SystemComplications and ill-defined descriptions of heart diseaseISRCTN29111908St George's, University of London (UK)20
招募中
不适用
Trans-catheter aortic valve implantatioSevere aortic valve stenosisJPRN-UMIN000006880Osaka University Graduate School of medicine Department of Cardiovascular Surgery, Department of Cardiology53
终止
不适用
REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk SubjectsAortic Valve StenosisNCT03618095Boston Scientific Corporation382
招募中
不适用
Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-upsevere aortic valve stenosis10046973NL-OMON45149Medtronic B.V.160